Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
Positive pre-clinical in vivo data for three immuno-oncology candidates
Epitope-Steering and Antibody Optimization for Accelerating Cancer Immunotherapies
FROM PRECISION ANTIBODY IDENTIFICATION AND OPTIMIZATION TO TAILORED BI-SPECIFICS
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
License our discovery platform or collaborate with us to advance our high-value pipeline assets
a CD3-BASED T-CELL ENGAGER PANEL FOR
OPTIMIZING BI-SPECIFICS
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
Meet the team driving iBio’s powerful tech stack for drug discovery
For Investor inquiries, please visit our Investor Site